LGVNLongeveron Inc.Aug 12, 2026Q2 2026
Read transcript →Longeveron Inc. (LGVN) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.62
-3.68%
Mkt Cap $20.02M
LGVNLongeveron Inc.Aug 12, 2026LGVNLongeveron Inc.May 13, 2026Q1 2026
Read transcript →LGVNLongeveron Inc.Mar 17, 2026Q4 2025
Read transcript →LGVNLongeveron Inc.Nov 4, 2025Q3 2025
Read transcript →LGVNLongeveron Inc.Aug 13, 2025Q2 2025
Read transcript →LGVNLongeveron Inc.Feb 28, 2025Q4 2024
Read transcript →LGVNLongeveron Inc.Nov 12, 2024Q3 2024
Read transcript →LGVNLongeveron Inc.Aug 14, 2024Q2 2024
Read transcript →LGVNLongeveron Inc.May 14, 2024Q1 2024
Read transcript →LGVNLongeveron Inc.Feb 27, 2024Q4 2023
Read transcript →LGVNLongeveron Inc.Nov 10, 2023Q3 2023
Read transcript →LGVNLongeveron Inc.Aug 11, 2023Q2 2023
Read transcript →LGVNLongeveron Inc.May 12, 2023Q1 2023
Read transcript →LGVNLongeveron Inc.Mar 10, 2023Q4 2022
Read transcript →LGVNLongeveron Inc.Nov 14, 2022Q3 2022
Read transcript →LGVNLongeveron Inc.Aug 14, 2022Q2 2022
Read transcript →LGVNLongeveron Inc.May 17, 2022Q1 2022
Read transcript →LGVNLongeveron Inc.Mar 11, 2022Q4 2021
Read transcript →LGVNLongeveron Inc.Nov 12, 2021Q3 2021
Read transcript →LGVNLongeveron Inc.Aug 14, 2021Q2 2021
Read transcript →LGVNLongeveron Inc.May 14, 2021Q1 2021
Read transcript →LGVNLongeveron Inc.Mar 30, 2021Q4 2020
Read transcript →